These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11532741)

  • 21. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia].
    Karniol IG; Giampietro AC; Moura DS; Vilela WA; Oliveira MA; Zuardi AW
    Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical trial of nifedipine in schizophrenia and tardive dyskinesia.
    Suddath RL; Straw GM; Freed WJ; Bigelow LB; Kirch DG; Wyatt RJ
    Pharmacol Biochem Behav; 1991 Jul; 39(3):743-5. PubMed ID: 1686106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo.
    Sommer BR; Cohen BM; Satlin A; Cole JO; Jandorf L; Dorsey F
    J Geriatr Psychiatry Neurol; 1994; 7(4):234-7. PubMed ID: 7826493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
    Dabiri LM; Pasta D; Darby JK; Mosbacher D
    Am J Psychiatry; 1994 Jun; 151(6):925-6. PubMed ID: 8185007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Xu CQ; Chen DC; Wu GY
    J Clin Psychopharmacol; 2004 Feb; 24(1):83-6. PubMed ID: 14709952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.
    Pappa S; Tsouli S; Apostolou G; Mavreas V; Konitsiotis S
    Clin Neuropharmacol; 2010; 33(6):271-5. PubMed ID: 21121175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is diltiazem effective in treating the symptoms of (tardive) dyskinesia in chronic psychiatric inpatients? A negative, double-blind, placebo-controlled trial.
    Loonen AJ; Verwey HA; Roels PR; van Bavel LP; Doorschot CH
    J Clin Psychopharmacol; 1992 Feb; 12(1):39-42. PubMed ID: 1348061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A crossover study of lecithin treatment of tardive dyskinesia.
    Gelenberg AJ; Dorer DJ; Wojcik JD; Falk WE; Brotman AW; Leahy L
    J Clin Psychiatry; 1990 Apr; 51(4):149-53. PubMed ID: 2182613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
    Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
    Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia.
    Dorevitch A; Lerner V; Shalfman M; Kalian M
    Int Clin Psychopharmacol; 1997 May; 12(3):171-3. PubMed ID: 9248874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of 37 cases of tardive dyskinesia by deanol].
    Cai N
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):234-6. PubMed ID: 4075918
    [No Abstract]   [Full Text] [Related]  

  • 34. Benefits of trazodone and mianserin for patients with late-life chronic schizophrenia and tardive dyskinesia: an add-on, double-blind, placebo-controlled study.
    Hayashi T; Yokota N; Takahashi T; Tawara Y; Nishikawa T; Yano T; Furutani M; Fujikawa T; Horiguchi J; Yamawaki S
    Int Clin Psychopharmacol; 1997 Jul; 12(4):199-205. PubMed ID: 9347380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of tardive dyskinesia with lecithin.
    Jackson IV; Nuttall EA; Ibe IO; Perez-Cruet J
    Am J Psychiatry; 1979 Nov; 136(11):1458-60. PubMed ID: 40440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.
    Adler LA; Rotrosen J; Edson R; Lavori P; Lohr J; Hitzemann R; Raisch D; Caligiuri M; Tracy K
    Arch Gen Psychiatry; 1999 Sep; 56(9):836-41. PubMed ID: 12892048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naltrexone treatment of tardive dyskinesia in patients with schizophrenia.
    Wonodi I; Adami H; Sherr J; Avila M; Hong LE; Thaker GK
    J Clin Psychopharmacol; 2004 Aug; 24(4):441-5. PubMed ID: 15232337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin E in tardive dyskinesia: time course of effect after placebo substitution.
    Adler LA; Peselow E; Duncan E; Rosenthal M; Angrist B
    Psychopharmacol Bull; 1993; 29(3):371-4. PubMed ID: 8121964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.